|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
12.31(B) |
Last
Volume: |
409,225 |
Avg
Vol: |
473,087 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 12.5 |
Insider 3/6 Months : 13.1 |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
6,942 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$1,248,939 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
2 |
3 |
3 |
Total Buy Transactions |
0 |
2 |
3 |
5 |
Total Shares Sold |
23,114 |
39,618 |
49,144 |
90,567 |
Total Sell Value |
$5,787,506 |
$8,980,179 |
$11,008,736 |
$21,109,640 |
Total People Sold |
5 |
5 |
6 |
8 |
Total Sell Transactions |
7 |
10 |
16 |
26 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Andrews Nancy C |
Director |
|
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
575 |
1,795 |
|
- |
|
Bertolini Robert J |
Director |
|
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
980 |
30,717 |
|
- |
|
Massaro George |
Director |
|
2022-05-09 |
4 |
AS |
$228.62 |
$41,110 |
D/D |
(178) |
4,677 |
|
-13% |
|
Pease Flavia |
Corporate Executive VP |
|
2022-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,185 |
5,185 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-03-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
754 |
18,844 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-03-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
754 |
3,015 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2022-03-03 |
4 |
S |
$281.49 |
$2,532,921 |
D/D |
(8,965) |
25,819 |
|
25% |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2022-03-03 |
4 |
OE |
$109.34 |
$1,224,594 |
D/D |
8,965 |
34,784 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,152 |
25,819 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2022-02-23 |
4 |
AS |
$283.89 |
$5,841,869 |
D/D |
(20,296) |
215,022 |
|
-21% |
|
Foster James C |
Chairman, President and CEO |
|
2022-02-23 |
4 |
OE |
$109.34 |
$2,219,165 |
D/D |
20,296 |
235,318 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2022-02-23 |
4 |
D |
$289.58 |
$108,303 |
D/D |
(374) |
20,667 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-02-23 |
4 |
S |
$292.75 |
$115,636 |
D/D |
(395) |
19,852 |
|
21% |
|
Foster James C |
Chairman, President and CEO |
|
2022-02-23 |
4 |
D |
$289.58 |
$512,557 |
D/D |
(1,770) |
215,022 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-02-23 |
4 |
D |
$289.58 |
$91,218 |
D/D |
(315) |
3,769 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2022-02-23 |
4 |
D |
$289.58 |
$81,082 |
D/D |
(280) |
33,669 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2022-02-23 |
4 |
D |
$289.58 |
$16,216 |
D/D |
(56) |
6,038 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-02-23 |
4 |
D |
$289.58 |
$91,218 |
D/D |
(315) |
20,247 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2022-02-22 |
4 |
D |
$293.61 |
$100,121 |
D/D |
(341) |
21,041 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2022-02-22 |
4 |
AS |
$285.88 |
$5,033,328 |
D/D |
(17,436) |
216,792 |
|
-24% |
|
Foster James C |
Chairman, President and CEO |
|
2022-02-22 |
4 |
OE |
$144.67 |
$2,522,466 |
D/D |
17,436 |
234,228 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2022-02-22 |
4 |
D |
$293.61 |
$472,712 |
D/D |
(1,610) |
216,792 |
|
- |
|
Wallman Richard F |
Director |
|
2022-02-22 |
4 |
S |
$288.05 |
$936,163 |
I/I |
(3,250) |
0 |
|
24% |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2022-02-22 |
4 |
D |
$293.61 |
$52,850 |
D/D |
(180) |
9,770 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-02-22 |
4 |
D |
$293.61 |
$84,266 |
D/D |
(287) |
4,084 |
|
- |
|
2014 Records found
|
|
Page 8 of 81 |
|
|